Conjunctivitis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
[[Secondary prevention]] strategies following conjunctivitis include discontinued [[contact lens]] wear (infective conjunctivitis), [[ocular]] [[prophylaxis]] with 0.5% [[erythromycin]] [[ointment]] or 1% [[tetracycline hydrochloride]] ([[ophthalmia neonatorum]]) and avoiding the offending [[antigen]] ([[allergic conjunctivitis]]). | [[Secondary prevention]] strategies following conjunctivitis include discontinued [[contact lens]] wear (infective conjunctivitis), [[ocular]] [[prophylaxis]] with 0.5% [[erythromycin]] [[ointment]] or 1% [[tetracycline hydrochloride]] ([[ophthalmia neonatorum]]) and avoiding the offending [[antigen]] ([[allergic conjunctivitis]]). | ||
Secondary prevention strategies following [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome)]] include avoiding very dry environments, dusty and smoky areas and prolonged [[visual]] tasks. | Secondary prevention strategies following [[keratoconjunctivitis sicca|keratoconjunctivitis sicca (dry eye syndrome)]] include avoiding very dry environments, dusty and smoky areas and prolonged [[visual]] tasks. | ||
There is no established method for secondary prevention of superior limbic | There is no established method for secondary prevention of [[superior limbic keratoconjunctivitis|superior limbic keratoconjunctivitis (SLK)]]. However, educating patients about disease process can improve [[compliance]] of patients with treatment, and help them to cope with the often prolonged [[symptoms]].<ref name="pmid17696792">{{cite journal| author=Rose P| title=Management strategies for acute infective conjunctivitis in primary care: a systematic review. | journal=Expert Opin Pharmacother | year= 2007 | volume= 8 | issue= 12 | pages= 1903-21 | pmid=17696792 | doi=10.1517/14656566.8.12.1903 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17696792 }} </ref><ref name="pmid24235191">{{cite journal| author=Matejcek A, Goldman RD| title=Treatment and prevention of ophthalmia neonatorum. | journal=Can Fam Physician | year= 2013 | volume= 59 | issue= 11 | pages= 1187-90 | pmid=24235191 | doi= | pmc=3828094 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24235191 }} </ref><ref name="pmid23497516">{{cite journal| author=La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S et al.| title=Allergic conjunctivitis: a comprehensive review of the literature. | journal=Ital J Pediatr | year= 2013 | volume= 39 | issue= | pages= 18 | pmid=23497516 | doi=10.1186/1824-7288-39-18 | pmc=3640929 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23497516 }} </ref><ref name="pmid25686388">{{cite journal| author=Messmer EM| title=The pathophysiology, diagnosis, and treatment of dry eye disease. | journal=Dtsch Arztebl Int | year= 2015 | volume= 112 | issue= 5 | pages= 71-81; quiz 82 | pmid=25686388 | doi=10.3238/arztebl.2015.0071 | pmc=4335585 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25686388 }} </ref><ref name="pmid2695351">{{cite journal| author=Nelson JD| title=Superior limbic keratoconjunctivitis (SLK). | journal=Eye (Lond) | year= 1989 | volume= 3 ( Pt 2) | issue= | pages= 180-9 | pmid=2695351 | doi=10.1038/eye.1989.26 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2695351 }} </ref> | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
| Line 26: | Line 26: | ||
*Avoiding prolonged [[visual]] tasks (staring at a computer screen, driving, watching television, and reading) | *Avoiding prolonged [[visual]] tasks (staring at a computer screen, driving, watching television, and reading) | ||
===Superior Limbic Keratoconjunctivitis=== | ===Superior Limbic Keratoconjunctivitis=== | ||
There is no established method for [[secondary prevention]] of superior limbic keratoconjunctivitis. However, educating patients about disease process can improve [[compliance]] of patients with treatment, and help them to cope with the often prolonged [[symptoms]].<ref name="pmid2695351">{{cite journal| author=Nelson JD| title=Superior limbic keratoconjunctivitis (SLK). | journal=Eye (Lond) | year= 1989 | volume= 3 ( Pt 2) | issue= | pages= 180-9 | pmid=2695351 | doi=10.1038/eye.1989.26 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2695351 }} </ref> | There is no established method for [[secondary prevention]] of [[superior limbic keratoconjunctivitis|superior limbic keratoconjunctivitis (SLK)]]. However, educating patients about disease process can improve [[compliance]] of patients with treatment, and help them to cope with the often prolonged [[symptoms]].<ref name="pmid2695351">{{cite journal| author=Nelson JD| title=Superior limbic keratoconjunctivitis (SLK). | journal=Eye (Lond) | year= 1989 | volume= 3 ( Pt 2) | issue= | pages= 180-9 | pmid=2695351 | doi=10.1038/eye.1989.26 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2695351 }} </ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 13:52, 11 July 2016
|
Conjunctivitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Conjunctivitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Conjunctivitis secondary prevention |
|
Risk calculators and risk factors for Conjunctivitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Secondary prevention strategies following conjunctivitis include discontinued contact lens wear (infective conjunctivitis), ocular prophylaxis with 0.5% erythromycin ointment or 1% tetracycline hydrochloride (ophthalmia neonatorum) and avoiding the offending antigen (allergic conjunctivitis). Secondary prevention strategies following keratoconjunctivitis sicca (dry eye syndrome) include avoiding very dry environments, dusty and smoky areas and prolonged visual tasks. There is no established method for secondary prevention of superior limbic keratoconjunctivitis (SLK). However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.[1][2][3][4][5]
Secondary Prevention
Infective Conjunctivitis
Effective measure for the secondary prevention of infective conjunctivitis include:[1]
- Discontinued contact lens wear (infective Conjunctivitis)
Neonatal Conjunctivitis
Effective measures for the secondary prevention of neonatal conjunctivitis (ophthalmia neonatorum) include:[2]
- Ocular prophylaxis with 0.5% erythromycin ointment or 1% tetracycline hydrochloride be given to all newborns.
Allergic conjunctivitis
Effective measures for the secondary prevention of allergic conjunctivitis include:[3]
- Avoiding the offending antigen
- Discontinued contact lens wear
Keratoconjunctivitis Sicca
Effective measures for the secondary prevention of keratoconjunctivitis sicca (dry eye syndrome) include:[4]
- Avoiding very dry environments (Furnaces and air conditioning can dry the air)
- Using a humidifier (puts moisture back into the air to prevent dry eyes)
- Avoiding dusty and smoky areas
- Avoiding prolonged visual tasks (staring at a computer screen, driving, watching television, and reading)
Superior Limbic Keratoconjunctivitis
There is no established method for secondary prevention of superior limbic keratoconjunctivitis (SLK). However, educating patients about disease process can improve compliance of patients with treatment, and help them to cope with the often prolonged symptoms.[5]
References
- ↑ 1.0 1.1 Rose P (2007). "Management strategies for acute infective conjunctivitis in primary care: a systematic review". Expert Opin Pharmacother. 8 (12): 1903–21. doi:10.1517/14656566.8.12.1903. PMID 17696792.
- ↑ 2.0 2.1 Matejcek A, Goldman RD (2013). "Treatment and prevention of ophthalmia neonatorum". Can Fam Physician. 59 (11): 1187–90. PMC 3828094. PMID 24235191.
- ↑ 3.0 3.1 La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S; et al. (2013). "Allergic conjunctivitis: a comprehensive review of the literature". Ital J Pediatr. 39: 18. doi:10.1186/1824-7288-39-18. PMC 3640929. PMID 23497516.
- ↑ 4.0 4.1 Messmer EM (2015). "The pathophysiology, diagnosis, and treatment of dry eye disease". Dtsch Arztebl Int. 112 (5): 71–81, quiz 82. doi:10.3238/arztebl.2015.0071. PMC 4335585. PMID 25686388.
- ↑ 5.0 5.1 Nelson JD (1989). "Superior limbic keratoconjunctivitis (SLK)". Eye (Lond). 3 ( Pt 2): 180–9. doi:10.1038/eye.1989.26. PMID 2695351.